HOME >> MEDICINE >> NEWS
Recent study suggests that tooth loss/gum disease may be associated with heart disease

Boston, MA, August 12, 2003 Researchers have believed for years that there may be a relationship between gum disease and heart disease. Now, a study to be published in September by the American Heart Association suggests that a linkage between healthy gums and a healthy heart may exist.

The study, to be published in the September issue of Stroke: Journal of the American Heart Association, identified a potential link between tooth loss and atherosclerosis, the buildup of artery-clogging plaque that can lead to stroke or heart attack. Within this study, researchers speculate that tooth loss, frequently caused by gum disease, may spark a series of chemical reactions that cause inflammation throughout the body, contributing to coronary artery disease.

"Half of adults age 18 or older have some evidence of gingivitis, the earliest sign of gum disease," said Dr. Paul Warren, Vice President of Clinical Research for Oral-B. "The good news is that gingivitis can be prevented and even reversed with proper oral care."

In addition to proper diet, daily brushing and flossing, and frequent visits to the dentist, consumers can arm themselves against gum disease with the proper oral care tools. According to an independent study released earlier this year, only power toothbrushes with rotational oscillation technology, such as the Oral-B Professional Care 7000, are demonstrably more effective in removing plaque and reducing gingivitis than manual toothbrushes. No other forms of power toothbrushing -- including "sonic" -- proved to be any better than a manual toothbrush. This study, based on four decades of research, was conducted by the Cochrane Collaboration, a British-based non-profit health research group.

The Oral-B Professional Care 7000 is Oral-B's newest premium power toothbrush. Featuring a unique 3D pulsing/oscillation action that pulses and oscillates to break up plaque and sweep it away, the Oral-B Professional Care 7000 cleans below
'"/>

Contact: Stephanie De Fino
sdefino@porternovelli.com
212-601-8231
Porter Novelli
12-Aug-2003


Page: 1 2

Related medicine news :

1. Recent research finds boys have more literacy problems than girls
2. Recent trends in motorcycle fatalities
3. Postpartum Help Needed To Keep Recent Mothers From Resuming Smoking Habit
4. First head-to-head study to compare lidoderm patch and Celebrex in treating pain
5. UMaine study looks at infants and chronic nighttime crying
6. Chronic pain treatments more effective when taken together, new study shows
7. UNC study: Most N.C. family practitioners engage in unrecognized community service
8. New study in Nature demonstrates protection against cell death during heart attack
9. UCSF study offers insight into human circadian rhythms
10. International breast cancer prevention study launches in the United States and Canada
11. UW study shows blacks and Latinos are more satisfied with physicians of the same race

Post Your Comments:
(Date:4/24/2014)... from The University of Manchester have identified a way ... more open to treatment. , The study published today ... for the development of drugs to target cells that ... made the discovery whilst exploring the possible mechanisms behind ... treat breast and colon cancer. , Dr Andrew Gilmore, ...
(Date:4/24/2014)... with an antimicrobial peptide could help to lower the risk ... Optometry and Vision Science , official journal of the ... published by Lippincott Williams & Wilkins , a part ... and now humans support the biocompatibility and safety of lenses ... research by Debarun Dutta, B.Optom, of The University of New ...
(Date:4/24/2014)... new Institute for Biomedical Sciences at Georgia State ... grant to develop novel therapeutics against Respiratory Syncytial ... Eunice Kennedy Shriver National Institute Of Child Health ... Health will support Plemper,s drug development goals of ... distinct alternative compound. , Infections by RSV, a ...
(Date:4/24/2014)... than one out of three survivors of critical ... The Lancet Respiratory Medicine , and the ... than mentally. , It is one of the ... functional outcomes of critical care survivors, according to ... Medicine, and it highlights a significant public health ...
(Date:4/24/2014)... has found a relationship between motor skill deficiencies and ... in very young children. , The findings, believed ... relationship between motor skills and autism severity, indicate that ... included in treatment plans for young children with autism, ... of Public Health and Human Sciences. , "Recognizing ...
Breaking Medicine News(10 mins):Health News:Scientists find way to target cells resistant to chemo 2Health News:Study supports safety of antimicrobial peptide-coated contact lenses 2Health News:Study supports safety of antimicrobial peptide-coated contact lenses 3Health News:Vanderbilt study finds physical signs of depression common among ICU survivors 2Health News:Vanderbilt study finds physical signs of depression common among ICU survivors 3Health News:Motor skill deficiencies linked to autism severity in new research 2
(Date:1/15/2014)...  Echo Therapeutics, Inc. (Nasdaq: ECTE ) ("Echo"), ... as a non-invasive, wireless continuous glucose monitoring system, today ... and Interim CEO of Echo Therapeutics, will present at ... Mr. Doman will make a corporate ...
(Date:1/15/2014)... , Jan. 15, 2014 Reportlinker.com ... is available in its catalogue: ... Drug Forecast and Market Analysis to 2022 ... PharmaPoint: Atopic Dermatitis - India Drug Forecast ...
(Date:1/15/2014)... 15, 2014  Zafgen, Inc., a leading biopharmaceutical company ... obese patients, today announced initial results from its ... of methionine aminopeptidase 2 (MetAP2), in patients with ... obesity.  These results showed improvements in body weight, ...
Breaking Medicine Technology:Echo Therapeutics to Present at the Noble Financial Capital Markets' Tenth Annual Equity Conference 2Echo Therapeutics to Present at the Noble Financial Capital Markets' Tenth Annual Equity Conference 3PharmaPoint: Atopic Dermatitis - India Drug Forecast and Market Analysis to 2022 2PharmaPoint: Atopic Dermatitis - India Drug Forecast and Market Analysis to 2022 3PharmaPoint: Atopic Dermatitis - India Drug Forecast and Market Analysis to 2022 4PharmaPoint: Atopic Dermatitis - India Drug Forecast and Market Analysis to 2022 5Zafgen Announces Initial Results from Phase 2a Study of Beloranib in Patients with Prader-Willi Syndrome 2Zafgen Announces Initial Results from Phase 2a Study of Beloranib in Patients with Prader-Willi Syndrome 3Zafgen Announces Initial Results from Phase 2a Study of Beloranib in Patients with Prader-Willi Syndrome 4
Cached News: